DocG DocG | AI-Powered Clinical Summaries
← DocG Medical Summaries

Top Ophthalmology Research Papers

Live ranking — trailing 6 months, each paper's latest score Scores fold Ophthalmology Relevance & Applicability into the quality dimensions; papers scored before the dynamic-specialty rubric keep their original score Showing the top 10 of 34 ranked articles — sign in free for the full ranking and per-criterion score breakdowns
1. 7.0
Dexamethasone Eye Drops to Prevent Treatment-Requiring Retinopathy of Prematurity: The DROPROP Randomized Clinical Trial.
Overall: DROPROP is a well-designed but small randomized trial showing a large, clinically promising yet imprecise and statistically inconclusive reduction in treatment-requiring ROP with a practical topical intervention.
2. 6.9
Do Vitreous Floaters Predict Retinal Detachment? Retrospective Cohort Study in Primary Care.
Overall: This clinically relevant primary-care cohort identifies new, acute, or numerous floaters as meaningful warning signs for retinal detachment, but retrospective methods and the absence of tested referral or visual-outcome benefits limit certainty.
3. 6.5
Safety and efficacy of topical OCS-01 ophthalmic suspension for the treatment of diabetic macular oedema: stage 1 of a multicentre, double-blind, randomised, vehicle-controlled phase 2/3 trial.
Overall: This well-masked randomized trial found a modest short-term visual-acuity benefit from a burdensome topical regimen, but its exploratory size, attrition, and lack of longer-term efficacy and safety data make confirmatory results necessary.
4. 6.3
Impact of exercise on myopia in children and adolescents and its modifying factors: a systematic review and meta-analysis.
Overall: A sizable randomized-trial meta-analysis suggests exercise may modestly improve vision-related measures in young people, but uncertain clinical importance and limited applicability details make it supportive rather than clearly practice-changing evidence.
5. 5.8
CONCUSS randomised clinical trial of vergence/accommodative therapy for concussion-related symptomatic convergence insufficiency.
Overall: This randomized trial found large short-term clinical and symptom benefits from prompt specialized therapy, but its narrow population, surrogate-heavy primary outcome, unreported harms, and intensive referral-based treatment limit its impact on routine US primary care.
6. 5.6
Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis.
Overall: This large meta-analysis identifies a potentially serious but very rare GLP-1 receptor agonist safety signal that may inform counseling, although residual confounding and imprecise randomized evidence limit practice-changing implications.
7. 5.5
Association between model of anesthesiology care and outcomes after cataract surgery: a population-based cohort study.
Overall: A very large adjusted cohort study using patient-important outcomes suggests only small clinical differences between anesthesia care models for cataract surgery while increasing costs, limiting immediate, practice-level impact despite strong scale.
8. 5.4
An AI-Based OCT System to Detect Diabetic Macular Edema: A Prospective Validation and Noninferiority Randomized Clinical Trial.
Overall: This rigorous trial found a large reduction in unnecessary DME referrals without missed cases, but it evaluated a resource-dependent Hong Kong screening pathway and did not establish improved patient health outcomes.
9. 5.4
Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.
Overall: This large, clinically relevant cohort identifies a possible rare vision-related harm, but sparse events, residual confounding, attenuated sensitivity analyses, and tiny absolute differences substantially limit practice-changing implications.
10. 5.2
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy : A Target Trial Emulation.
Overall: This relevant US claims study identifies a possible but extremely rare ocular harm from GLP-1 receptor agonists, with insufficient causal certainty or absolute impact to support a major practice change.
Score Guide: 9-10 Exceptional 7-8 Strong 5-6 Moderate 3-4 Weak 1-2 Poor

Get the top Ophthalmology papers in your inbox

Free 300-word clinical summaries 3× per week, plus the full ranking of all 34 recent Ophthalmology papers with per-criterion AI score breakdowns.

Sign Up Free